Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
37 studies found for:    Open Studies | "Meningioma"
Show Display Options
Rank Status Study
21 Not yet recruiting Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Conditions: Childhood Choroid Plexus Tumor;   Childhood Ependymoblastoma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Medulloepithelioma;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: palbociclib isethionate;   Other: pharmacological study;   Other: laboratory biomarker analysis
22 Unknown  Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer
Interventions: Drug: verteporfin;   Procedure: conventional surgery
23 Unknown  Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
24 Recruiting Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Neuroblastoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: crizotinib;   Other: pharmacogenomic studies;   Other: pharmacological study
25 Unknown  Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
26 Recruiting Collecting and Storing Tissue From Young Patients With Cancer
Condition: Cancer
Interventions: Genetic: DNA analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis
27 Recruiting Enhancement of Neurocognitive Functions by Hippocampal Sparing Radiotherapy
Condition: Radiation of Neurocranial Region
Interventions: Radiation: Radiation according to indication with hippocampal sparing;   Radiation: Radiation according to indication without hippocampal protection
28 Unknown  Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
29 Unknown  Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
30 Recruiting Photodynamic Therapy (PDT) for Brain Tumors
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin (porfimer sodium) & photodynamic therapy.
31 Recruiting Dexanabinol in Patients With Brain Cancer
Condition: Brain Cancer
Intervention: Drug: Dexanabinol
32 Recruiting Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy
Condition: Brain Tumors
Intervention: Procedure: fMRI Evaluation
33 Not yet recruiting Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin photodynamic therapy.
34 Unknown  Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Metastatic Cancer
Interventions: Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique;   Procedure: magnetic resonance imaging
35 Recruiting Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Conditions: Central Nervous System Tumor, Pediatric;   Chemotherapy-induced Nausea and Vomiting;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Procedure: Real Acupressure Band;   Procedure: Placebo Acupressure Band
36 Unknown  Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Neuroblastoma;   Pheochromocytoma;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Radiation: yttrium Y 90-edotreotide
37 Recruiting Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
Condition: Brain Cancer
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years